Global Animal Biopharma Production, Demand and Key Producers, 2022-2028

October 2022 | 113 pages | ID: G247690750CAEN
GlobalInfoResearch

Abstracts

This report studies the global Animal Biopharma demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Animal Biopharma, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Animal Biopharma that contribute to its increasing demand across many markets.

The global Animal Biopharma market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Animal Biopharma total market, 2017-2028, (USD Million)

Global Animal Biopharma total market by region & country, CAGR, 2017-2028, (USD Million)

U.S. VS China: Animal Biopharma total market, key domestic companies and share, (USD Million)

Global Animal Biopharma revenue by player and market share 2017-2022, (USD Million)

Global Animal Biopharma total market by Type, CAGR, 2017-2028, (USD Million)

Global Animal Biopharma total market by Application, CAGR, 2017-2028, (USD Million)

This reports profiles major players in the global Animal Biopharma market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Invetx, CZ Vaccines, Scout Bio, Zoetis, Merck, Elanco, Virbac and Ceva, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Animal Biopharma market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Animal Biopharma Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Animal Biopharma Market, Segmentation by Type

• Vaccine (Bacteria)
• Immune Serum
• Antigen & Antibody
• Others

Global Animal Biopharma Market, Segmentation by Application

• Prevention
• Treatment

Companies Profiled:

• Boehringer Ingelheim
• Invetx
• CZ Vaccines
• Scout Bio
• Zoetis
• Merck
• Elanco
• Virbac
• Ceva
• Vetoquinol

Key Questions Answered

1. How big is the global Animal Biopharma market?

2. What is the demand of the global Animal Biopharma market?

3. What is the year over year growth of the global Animal Biopharma market?

4. What is the total value of the global Animal Biopharma market?

5. Who are the major players in the global Animal Biopharma market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Animal Biopharma Introduction
1.2 World Animal Biopharma Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Animal Biopharma Total Market by Region
  1.3.1 World Animal Biopharma Market Size by Region (2017-2028)
  1.3.2 United States Animal Biopharma Market Size (2017-2028)
  1.3.3 China Animal Biopharma Market Size (2017-2028)
  1.3.4 Europe Animal Biopharma Market Size (2017-2028)
  1.3.5 Japan Animal Biopharma Market Size (2017-2028)
  1.3.6 South Korea Animal Biopharma Market Size (2017-2028)
  1.3.7 ASEAN Animal Biopharma Market Size (2017-2028)
  1.3.8 India Animal Biopharma Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Animal Biopharma Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Animal Biopharma Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 WORLD ANIMAL BIOPHARMA COMPANIES COMPETITIVE ANALYSIS

2.1 World Animal Biopharma Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
  2.2.1 Global Animal Biopharma Industry Rank of Major Players
  2.2.2 Global Concentration Ratios (CR4) for Animal Biopharma in 2021
  2.2.3 Global Concentration Ratios (CR8) for Animal Biopharma in 2021
2.3 Animal Biopharma Company Evaluation Quadrant
2.4 Animal Biopharma Market: Overall Company Footprint Analysis
  2.4.1 Animal Biopharma Market: Region Footprint
  2.4.2 Animal Biopharma Market: Company Product Type Footprint
  2.4.3 Animal Biopharma Market: Company Product Application Footprint
2.5 Competitive Environment
  2.5.1 Historical Structure of the Industry
  2.5.2 Barriers of Market Entry
  2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity

3 UNITED STATES VS CHINA VS REST OF THE WORLD

3.1 United States VS China: Animal Biopharma Market Comparison
  3.1.1 United States VS China: Animal Biopharma Market Size Comparison (2017 & 2021 & 2028)
  3.1.2 United States VS China: Animal Biopharma Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Animal Biopharma Major Players and Market Share, 2017-2022
  3.2.1 Major Players of Animal Biopharma in United States, Headquarters (States, Country)
  3.2.2 United States Animal Biopharma Revenue by Domestic Player, (2017-2022)
3.3 China Animal Biopharma Major Players and Market Share, 2017-2022
  3.3.1 Major Players of Animal Biopharma in China, Headquarters (Province, Country)
  3.3.2 China Animal Biopharma Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Animal Biopharma Major Players and Market Share, 2017-2022
  3.4.1 Major Players of Animal Biopharma in Rest of World, Headquarters (State, Country)
  3.4.2 Rest of World Animal Biopharma Revenue by Domestic Player, (2017-2022)

4 MARKET ANALYSIS BY TYPE

4.1 World Animal Biopharma Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
  4.2.1 Vaccine (Bacteria)
  4.2.2 Immune Serum
  4.2.3 Antigen & Antibody
  4.2.4 Others
4.3 Market Segment by Type
  4.3.1 World Animal Biopharma Market Size by Type (2017-2022)
  4.3.2 World Animal Biopharma Market Size by Type (2023-2028)
  4.3.3 World Animal Biopharma Market Size Market Share by Type (2017-2028)

5 MARKET ANALYSIS BY APPLICATION

5.1 World Animal Biopharma Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
  5.2.1 Prevention
  5.2.2 Treatment
5.3 Market Segment by Application
  5.3.1 World Animal Biopharma Market Size by Application (2017-2022)
  5.3.2 World Animal Biopharma Market Size by Application (2023-2028)
  5.3.3 World Animal Biopharma Market Size by Application (2017-2028)

6 COMPANY PROFILES

6.1 Boehringer Ingelheim
  6.1.1 Boehringer Ingelheim Details
  6.1.2 Boehringer Ingelheim Major Business
  6.1.3 Boehringer Ingelheim Animal Biopharma Product and Services
  6.1.4 Boehringer Ingelheim Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022)
  6.1.5 Boehringer Ingelheim Recent Developments/Updates
  6.1.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
6.2 Invetx
  6.2.1 Invetx Details
  6.2.2 Invetx Major Business
  6.2.3 Invetx Animal Biopharma Product and Services
  6.2.4 Invetx Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022)
  6.2.5 Invetx Recent Developments/Updates
  6.2.6 Invetx Competitive Strengths & Weaknesses
6.3 CZ Vaccines
  6.3.1 CZ Vaccines Details
  6.3.2 CZ Vaccines Major Business
  6.3.3 CZ Vaccines Animal Biopharma Product and Services
  6.3.4 CZ Vaccines Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022)
  6.3.5 CZ Vaccines Recent Developments/Updates
  6.3.6 CZ Vaccines Competitive Strengths & Weaknesses
6.4 Scout Bio
  6.4.1 Scout Bio Details
  6.4.2 Scout Bio Major Business
  6.4.3 Scout Bio Animal Biopharma Product and Services
  6.4.4 Scout Bio Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022)
  6.4.5 Scout Bio Recent Developments/Updates
  6.4.6 Scout Bio Competitive Strengths & Weaknesses
6.5 Zoetis
  6.5.1 Zoetis Details
  6.5.2 Zoetis Major Business
  6.5.3 Zoetis Animal Biopharma Product and Services
  6.5.4 Zoetis Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022)
  6.5.5 Zoetis Recent Developments/Updates
  6.5.6 Zoetis Competitive Strengths & Weaknesses
6.6 Merck
  6.6.1 Merck Details
  6.6.2 Merck Major Business
  6.6.3 Merck Animal Biopharma Product and Services
  6.6.4 Merck Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022)
  6.6.5 Merck Recent Developments/Updates
  6.6.6 Merck Competitive Strengths & Weaknesses
6.7 Elanco
  6.7.1 Elanco Details
  6.7.2 Elanco Major Business
  6.7.3 Elanco Animal Biopharma Product and Services
  6.7.4 Elanco Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022)
  6.7.5 Elanco Recent Developments/Updates
  6.7.6 Elanco Competitive Strengths & Weaknesses
6.8 Virbac
  6.8.1 Virbac Details
  6.8.2 Virbac Major Business
  6.8.3 Virbac Animal Biopharma Product and Services
  6.8.4 Virbac Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022)
  6.8.5 Virbac Recent Developments/Updates
  6.8.6 Virbac Competitive Strengths & Weaknesses
6.9 Ceva
  6.9.1 Ceva Details
  6.9.2 Ceva Major Business
  6.9.3 Ceva Animal Biopharma Product and Services
  6.9.4 Ceva Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022)
  6.9.5 Ceva Recent Developments/Updates
  6.9.6 Ceva Competitive Strengths & Weaknesses
6.10 Vetoquinol
  6.10.1 Vetoquinol Details
  6.10.2 Vetoquinol Major Business
  6.10.3 Vetoquinol Animal Biopharma Product and Services
  6.10.4 Vetoquinol Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022)
  6.10.5 Vetoquinol Recent Developments/Updates
  6.10.6 Vetoquinol Competitive Strengths & Weaknesses

7 RAW MATERIAL AND INDUSTRY CHAIN

7.1 Raw Material of Animal Biopharma and Key Manufacturers
7.2 Animal Biopharma Manufacturing Costs
7.3 Animal Biopharma Production Process
7.4 Animal Biopharma Industrial Chain

8 DISTRIBUTION CHANNEL ANALYSIS

8.1 Distribution Channel Breakdown for Animal Biopharma Shipments (%): 2017-2028
  8.1.1 Direct Channel
  8.1.2 Indirect Channel
8.2 Animal Biopharma Typical Distributors
8.3 Animal Biopharma Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Animal Biopharma Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Animal Biopharma Market Size by Region (2017-2022) & (USD Million)
Table 3. World Animal Biopharma Market Size by Region (2023-2028) & (USD Million)
Table 4. World Animal Biopharma Market Size Market Share by Region (2017-2022)
Table 5. World Animal Biopharma Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Animal Biopharma Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Animal Biopharma Players in 2021
Table 9. World Animal Biopharma Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Animal Biopharma Company Evaluation Quadrant
Table 11. Head Office of Key Animal Biopharma Player
Table 12. Animal Biopharma Market: Company Product Type Footprint
Table 13. Animal Biopharma Market: Company Product Application Footprint
Table 14. Animal Biopharma Mergers & Acquisitions Activity
Table 15. United States VS China Animal Biopharma Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Animal Biopharma in United States, Headquarters (States, Country)
Table 17. United States Animal Biopharma Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Animal Biopharma Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Animal Biopharma in China, Company Headquarters (Province, Country)
Table 20. China Animal Biopharma Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Animal Biopharma Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Animal Biopharma in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Animal Biopharma Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Animal Biopharma Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Animal Biopharma Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Animal Biopharma Revenue by Type (2017-2022) & (USD Million)
Table 27. World Animal Biopharma Revenue by Type (2023-2028) & (USD Million)
Table 28. World Animal Biopharma Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Animal Biopharma Revenue by Application (2017-2022) & (USD Million)
Table 30. World Animal Biopharma Revenue by Application (2023-2028) & (USD Million)
Table 31. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 32. Boehringer Ingelheim Major Business
Table 33. Boehringer Ingelheim Animal Biopharma Product and Services
Table 34. Boehringer Ingelheim Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Boehringer Ingelheim Recent Developments/Updates
Table 36. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 37. Invetx Basic Information, Manufacturing Base and Competitors
Table 38. Invetx Major Business
Table 39. Invetx Animal Biopharma Product and Services
Table 40. Invetx Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Invetx Recent Developments/Updates
Table 42. Invetx Competitive Strengths & Weaknesses
Table 43. CZ Vaccines Basic Information, Manufacturing Base and Competitors
Table 44. CZ Vaccines Major Business
Table 45. CZ Vaccines Animal Biopharma Product and Services
Table 46. CZ Vaccines Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. CZ Vaccines Recent Developments/Updates
Table 48. CZ Vaccines Competitive Strengths & Weaknesses
Table 49. Scout Bio Basic Information, Manufacturing Base and Competitors
Table 50. Scout Bio Major Business
Table 51. Scout Bio Animal Biopharma Product and Services
Table 52. Scout Bio Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Scout Bio Recent Developments/Updates
Table 54. Scout Bio Competitive Strengths & Weaknesses
Table 55. Zoetis Basic Information, Manufacturing Base and Competitors
Table 56. Zoetis Major Business
Table 57. Zoetis Animal Biopharma Product and Services
Table 58. Zoetis Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Zoetis Recent Developments/Updates
Table 60. Zoetis Competitive Strengths & Weaknesses
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Animal Biopharma Product and Services
Table 64. Merck Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Elanco Basic Information, Manufacturing Base and Competitors
Table 68. Elanco Major Business
Table 69. Elanco Animal Biopharma Product and Services
Table 70. Elanco Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Elanco Recent Developments/Updates
Table 72. Elanco Competitive Strengths & Weaknesses
Table 73. Virbac Basic Information, Manufacturing Base and Competitors
Table 74. Virbac Major Business
Table 75. Virbac Animal Biopharma Product and Services
Table 76. Virbac Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Virbac Recent Developments/Updates
Table 78. Virbac Competitive Strengths & Weaknesses
Table 79. Ceva Basic Information, Manufacturing Base and Competitors
Table 80. Ceva Major Business
Table 81. Ceva Animal Biopharma Product and Services
Table 82. Ceva Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Ceva Recent Developments/Updates
Table 84. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 85. Vetoquinol Major Business
Table 86. Vetoquinol Animal Biopharma Product and Services
Table 87. Vetoquinol Animal Biopharma Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 88. Animal Biopharma Raw Material
Table 89. Key Manufacturers of Animal Biopharma Raw Materials
Table 90. Animal Biopharma Typical Distributors
Table 91. Animal Biopharma Typical Customers
List of Figure
Figure 1. Animal Biopharma Picture
Figure 2. World Animal Biopharma Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Animal Biopharma Total Market Size (2017-2028) & (USD Million)
Figure 4. World Animal Biopharma Market Size Market Share by Region (2017-2028)
Figure 5. United States Animal Biopharma Market Size (2017-2028) & (USD Million)
Figure 6. China Animal Biopharma Market Size (2017-2028) & (USD Million)
Figure 7. Europe Animal Biopharma Market Size (2017-2028) & (USD Million)
Figure 8. Japan Animal Biopharma Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Animal Biopharma Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Animal Biopharma Market Size (2017-2028) & (USD Million)
Figure 11. India Animal Biopharma Market Size (2017-2028) & (USD Million)
Figure 12. Animal Biopharma Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Animal Biopharma by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Animal Biopharma Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Animal Biopharma Markets in 2021
Figure 17. United States VS China: Animal Biopharma Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Animal Biopharma Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Animal Biopharma Market Size Market Share by Type in 2021
Figure 20. Vaccine (Bacteria)
Figure 21. Immune Serum
Figure 22. Antigen & Antibody
Figure 23. Others
Figure 24. World Animal Biopharma Market Size Market Share by Type (2017-2028)
Figure 25. World Animal Biopharma Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 26. World Animal Biopharma Market Size Market Share by Application in 2021
Figure 27. Prevention
Figure 28. Treatment
Figure 29. World Animal Biopharma Market Size Market Share by Application (2017-2028)
Figure 30. Manufacturing Cost Structure Analysis of Animal Biopharma in 2021
Figure 31. Manufacturing Process Analysis of Animal Biopharma
Figure 32. Animal Biopharma Industrial Chain
Figure 33. Distribution Channel Breakdown for Animal Biopharma Shipments (%): 2017-2028
Figure 34. Direct Channel Pros & Cons
Figure 35. Indirect Channel Pros & Cons
Figure 36. Methodology
Figure 37. Research Process and Data Source